| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 23, 2006
From the Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre (D.T.K., D.A.A., J.V.T.), Institute for Clinical Evaluative Sciences (D.T.K., J.J.Y., D.A.A., T.A.S., A.M.N., J.V.T.), Toronto, Ontario, Canada; Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine (H.M.K., Y.W.), Section of Health Policy and Administration, Department of Epidemiology and Public Health (H.M.K.), Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine (H.M.K.), and the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.), New Haven, Conn; Yale University School of Medicine, Section of Cardiovascular Medicine, West Haven Veteran’s Administration Medical Center, West Haven, CT Qualidigm, Middletown, Conn (J.M.F.); Department of Medicine, Denver Health Medical Center (F.A.M., E.P.H.), Department of Medicine, University of Colorado Health Sciences Center (F.A.M., E.P.H.), Denver, Col; Center for the Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH (T.A.S.); and Division of General Internal Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (J.V.T.). * To whom correspondence should be addressed. E-mail: tu{at}ices.on.ca.
Background--Previous comparisons of acute myocardial infarction (AMI) treatment between the United States and Canada are limited because they compared selected patients from randomized trials, used administrative data that lacked clinical detail, or did not consider regional differences in AMI treatment. Methods and Results--We compared medication use, invasive cardiac procedure use, and 30-day risk-standardized mortality rates of 38 886 fee-for-service Medicare beneficiaries hospitalized with AMI in the United States and 5634 similarly aged patients in Ontario, Canada, from 1998 and 2001. Baseline characteristics and illness severity across the US regions and Ontario were not substantially different. Cardiac catheterization use in AMI patients was significantly higher in the United States compared with Ontario (38.7% versus 16.8%, P<0.001), but significant regional variations existed, in which the northeastern United States had significantly lower utilization rates (25.6%) compared with other US regions. Conclusions--Previous studies have suggested a clear divergence in invasive cardiac therapy for AMI patients between the United States and Canada on the basis of health care financing and structural differences. Our findings of similar treatment patterns in the northeastern United States and Ontario suggest that regional practices may have a greater impact on treatment patterns than the respective health care delivery systems.
Accepted on October 19, 2006
Regional Differences in Process of Care and Outcomes for Older Acute Myocardial Infarction Patients in the United States and Ontario, Canada
Dennis T. Ko MD, MSc,
-Blocker use among ideal candidates was highest in the northeastern United States (77.6% versus 69.7% in the United States as a whole, P<0.001) and angiotensin-converting enzyme inhibitor use was highest in Ontario (69.1% versus 58.2% in the United States, P<0.001). Risk-standardized mortality rates at 30 days were not substantially different across the regions.
This article has been cited by other articles:
![]() |
T. R. Vogel, J. C. Cantor, V. Y. Dombrovskiy, P. B. Haser, and A. M. Graham AAA Repair: Sociodemographic Disparities in Management and Outcomes Vascular and Endovascular Surgery, January 1, 2009; 42(6): 555 - 560. [Abstract] [PDF] |
||||
![]() |
J. V. Tu and D. T. Ko Ecological Studies and Cardiovascular Outcomes Research Circulation, December 9, 2008; 118(24): 2588 - 2593. [Full Text] [PDF] |
||||
![]() |
G. F. Anderson and B. K. Frogner Health Spending In OECD Countries: Obtaining Value Per Dollar Health Aff., November 1, 2008; 27(6): 1718 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ross and A. S. Detsky Comparison of the US and Canadian Health Care Systems: A Tale of 2 Mount Sinai's JAMA, October 22, 2008; 300(16): 1934 - 1936. [Full Text] [PDF] |
||||
![]() |
B. K. Nallamothu, R. A. Hayward, and E. R. Bates Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies Circulation, September 16, 2008; 118(12): 1294 - 1303. [Full Text] [PDF] |
||||
![]() |
D. W. Jones, E. D. Peterson, R. O. Bonow, F. A. Masoudi, G. C. Fonarow, S. C. Smith Jr, P. Solis, M. Girgus, P. C. Hinton, A. Leonard, et al. Translating Research Into Practice for Healthcare Providers: The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke Circulation, August 5, 2008; 118(6): 687 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz Outcomes Research: Generating Evidence for Best Practice and Policies Circulation, July 15, 2008; 118(3): 309 - 318. [Full Text] [PDF] |
||||
![]() |
D. T. Ko, Y. Wang, D. A. Alter, J. P. Curtis, S. S. Rathore, T. A. Stukel, F. A. Masoudi, J. S. Ross, J. M. Foody, and H. M. Krumholz Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 716 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaul and E.D. Peterson The Cardiovascular World Is Definitely Not Flat Circulation, January 16, 2007; 115(2): 158 - 160. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |